3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
43
Stomach Neoplasms
42
Rectal Neoplasms
28
Pancreatic Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
13
Colonic Neoplasms
13
Cholangiocarcinoma
11
Neoplasm Metastasis
10
Adenocarcinoma
10
Neoplasms
9
Carcinoma, Hepatocellular
8
Carcinoma, Non-Small-Cell Lung
7
Biliary Tract Neoplasms
7
Locally Advanced Rectal Cancer
6
Gastrointestinal Neoplasms
6
Gallbladder Neoplasms
6
Esophageal Neoplasms
6
Adenocarcinoma Of Esophagus
6
Peritoneal Neoplasms
5
Recurrence
4
Ovarian Neoplasms
4
Esophageal Squamous Cell Carcinoma
3
Carcinoma
3
Bile Duct Neoplasms
3
Appendiceal Neoplasms
3
Advanced Solid Tumors
3
Advanced Solid Tumor
3
Pathologic Complete Response
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Interventions
trifluridine tipiracil drug combination
1
Trastuzumab
1
Panitumumab
1
Oxaliplatin
1
Nivolumab
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Dihydropyrimidine Dehydrogenase Deficiency
×
Oxaliplatin
×
Clear all
NCT06245356
2025-12-10
TRIFLUOX-DP
UNICANCER
Phase 2
Recruiting
73 enrolled